{"nct_id":"NCT04008706","title":"Acalabrutinib Safety Study in Untreated and Relapsed or Refractory Chronic Lymphocytic Leukemia Patients","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-09","start_date":"2019-09-17","start_date_type":"ACTUAL","primary_completion_date":"2025-09-01","primary_completion_date_type":"ESTIMATED","completion_date":"2025-09-01","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["AZN"]}